Pregabalin BP 165 mg (Lyrica) is a medication commonly used to treat various conditions related to nerve pain, seizures, and anxiety disorders. It is marketed under the brand name Lyrica and is widely prescribed for conditions like neuropathic pain, fibromyalgia, generalized anxiety disorder, and as an adjunct therapy for partial-onset seizures.

Pregabalin BP 165 mg (Lyrica)

Product Overview: Pregabalin BP 165 mg (Lyrica) is an oral medication primarily used for the management of neuropathic pain, fibromyalgia, generalized anxiety disorder (GAD), and as an adjunct therapy for partial-onset seizures. Pregabalin is a GABA analogue that works by binding to calcium channels in the central nervous system, reducing the release of excitatory neurotransmitters and decreasing the nerve signals that cause pain and seizures.

Key Benefits:

• Effective management of neuropathic pain due to diabetes, shingles, or spinal cord injury.
• Helps alleviate symptoms of fibromyalgia, including widespread pain and tenderness.
• Provides relief from generalized anxiety disorder (GAD).
• Used as adjunctive therapy to control partial-onset seizures in combination with other antiepileptic drugs.
• Convenient oral dosage for once-daily or divided doses, depending on patient needs.

Indications:

• Neuropathic pain associated with diabetic peripheral neuropathy, post-herpetic neuralgia, or spinal cord injury.
• Fibromyalgia, to help manage widespread musculoskeletal pain.
• Generalized anxiety disorder (GAD) in adults.
• As an adjunct therapy for the treatment of partial-onset seizures in patients with epilepsy.

Dosage:

• The recommended dose of Pregabalin BP 165 mg (Lyrica) is typically 165 mg once daily or 82.5 mg twice daily, depending on the condition being treated and the patient’s response.
• Your healthcare provider will determine the optimal dose and may adjust it based on effectiveness and tolerability.
• It can be taken with or without food.

Precautions:

• Kidney function: Patients with kidney impairment may require dose adjustments. Kidney function should be monitored during treatment.
• Drowsiness and dizziness: Pregabalin can cause drowsiness, dizziness, and blurred vision. Patients should be cautious when performing tasks that require alertness (e.g., driving).
• Discontinuation: Abrupt discontinuation of Lyrica can lead to withdrawal symptoms, such as insomnia, headache, nausea, and anxiety. It should be tapered off under a healthcare provider’s supervision.
• Pregnancy and breastfeeding: Consult your doctor before using Lyrica if you are pregnant or breastfeeding, as the medication may not be safe during these times.

Common Side Effects:

• Drowsiness or sedation
• Dizziness or lightheadedness
• Weight gain or increased appetite
• Swelling (edema), especially in the hands and feet
• Dry mouth
• Blurred vision
• Difficulty concentrating

Packaging:

• Pregabalin BP 165 mg (Lyrica) is available in convenient oral capsule form, packaged securely in [insert packaging type] to ensure easy storage and access.

Important Notes:

• Adherence to the prescribed dosage and regimen is crucial for optimal therapeutic effect. Do not adjust the dose without consulting your healthcare provider.
• If you miss a dose, take it as soon as you remember unless it’s close to the time for your next dose. Do not double doses.
• Store in a cool, dry place, away from moisture and direct sunlight, and out of reach of children.